IMMUNE MECHANISM AND THERAPEUTIC DRUG FOR BILIARY ATRESIA

摘要

A drug and a method for preventing/treating biliary atresia, the method comprising administering a drug for removing B cells to a subject, wherein the drug for removing B cells is selected from a CD20 inhibitor, a B cell maturation antigen inhibitor, and a CD79 inhibitor. The CD20 inhibitor is selected from rituximab, ibritumomab, tositumomab or an analog thereof, and has a certain significance for the clinical treatment of biliary atresia.